Matching articles for "Pneumo 23"

Pneumococcal Vaccination of Adults: Polysaccharide or Conjugate?

   
The Medical Letter on Drugs and Therapeutics • June 15, 2009;  (Issue 1314)
A 23-valent polysaccharide vaccine (PPSV23; Pneumovax 23 - Merck) is the only pneumococcal vaccine approved for use in adults. It has reduced the risk of invasive pneumococcal disease (meningitis or bacteremic...
A 23-valent polysaccharide vaccine (PPSV23; Pneumovax 23 - Merck) is the only pneumococcal vaccine approved for use in adults. It has reduced the risk of invasive pneumococcal disease (meningitis or bacteremic pneumonia), but not mortality, in immunocompetent older adults.2 PPSV23 has not been shown to reduce the risk of invasive pneumococcal disease (IPD) in immunocompromised patients.

Click here to view the free full article.
Med Lett Drugs Ther. 2009 Jun 15;51(1314):47-8 | Show Full IntroductionHide Full Introduction